Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360754311> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4360754311 endingPage "542" @default.
- W4360754311 startingPage "542" @default.
- W4360754311 abstract "<h3>Objective.</h3> —To improve current adjuvant results in patients with resectable mammary carcinoma and more than three positive axillary lymph nodes. <h3>Design.</h3> —A prospective randomized study was carried out to compare the effectiveness of four courses of doxorubicin hydrochloride followed by eight courses of cyclophosphamide, methotrexate, and fluorouracil (CMF) (sequential regimen) vs two courses of CMF alternated with one course of doxorubicin for a total of 12 courses (alternating regimen). All drug courses were recycled every 3 weeks. The median duration of follow-up at the time of current analysis was 9 years. <h3>Setting.</h3> —The study was conducted on patients operated on for primary unilateral breast cancer at the Istituto Nazionale Tumori of Milan, Italy. Adjuvant chemotherapy was delivered in the outpatient clinic of the Division of Medical Oncology. <h3>Patients.</h3> —A total of 405 women were entered into the study, 403 of whom met the protocol criteria. Patient characteristics were fairly well balanced between the two treatment groups, with the exception of extent of nodal involvement: 38% with more than 10 positive nodes were randomized to the alternating regimen compared with 29% in the sequential regimen (<i>P</i>=.08). <h3>Main Outcome Measure.</h3> —Relapse-free and total survival at 10 years after surgery estimated according to the Kaplan-Meier product limit method. <h3>Results.</h3> —Treatment outcome was significantly superior for patients who received the sequential regimen compared with those given the alternating chemotherapy. The relapse-free survival was 42% vs 28% (<i>P</i>=.002) and total survival was 58% vs 44% (<i>P</i>=.002), respectively. The benefit of the sequential regimen was evident in all patient subsets. Treatment was fairly well tolerated, but we documented four cases of congestive heart failure, which was fatal in two patients. <h3>Conclusions.</h3> —Current findings indicate that in women with extensive nodal involvement, sequential chemotherapy with doxorubicin followed by CMF yields superior results compared with the alternating administration of the same regimens or with classical CMF. (<i>JAMA</i>. 1995;273:542-547)" @default.
- W4360754311 created "2023-03-25" @default.
- W4360754311 creator A5023558260 @default.
- W4360754311 date "1995-02-15" @default.
- W4360754311 modified "2023-10-11" @default.
- W4360754311 title "Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive Nodes" @default.
- W4360754311 doi "https://doi.org/10.1001/jama.1995.03520310040027" @default.
- W4360754311 hasPublicationYear "1995" @default.
- W4360754311 type Work @default.
- W4360754311 citedByCount "162" @default.
- W4360754311 countsByYear W43607543112012 @default.
- W4360754311 countsByYear W43607543112013 @default.
- W4360754311 countsByYear W43607543112014 @default.
- W4360754311 countsByYear W43607543112015 @default.
- W4360754311 countsByYear W43607543112016 @default.
- W4360754311 countsByYear W43607543112017 @default.
- W4360754311 countsByYear W43607543112018 @default.
- W4360754311 countsByYear W43607543112019 @default.
- W4360754311 countsByYear W43607543112021 @default.
- W4360754311 countsByYear W43607543112022 @default.
- W4360754311 countsByYear W43607543112023 @default.
- W4360754311 crossrefType "journal-article" @default.
- W4360754311 hasAuthorship W4360754311A5023558260 @default.
- W4360754311 hasConcept C121608353 @default.
- W4360754311 hasConcept C126322002 @default.
- W4360754311 hasConcept C141071460 @default.
- W4360754311 hasConcept C143998085 @default.
- W4360754311 hasConcept C168563851 @default.
- W4360754311 hasConcept C2776694085 @default.
- W4360754311 hasConcept C2776755627 @default.
- W4360754311 hasConcept C2777649267 @default.
- W4360754311 hasConcept C2780456651 @default.
- W4360754311 hasConcept C2781413609 @default.
- W4360754311 hasConcept C530470458 @default.
- W4360754311 hasConcept C71924100 @default.
- W4360754311 hasConceptScore W4360754311C121608353 @default.
- W4360754311 hasConceptScore W4360754311C126322002 @default.
- W4360754311 hasConceptScore W4360754311C141071460 @default.
- W4360754311 hasConceptScore W4360754311C143998085 @default.
- W4360754311 hasConceptScore W4360754311C168563851 @default.
- W4360754311 hasConceptScore W4360754311C2776694085 @default.
- W4360754311 hasConceptScore W4360754311C2776755627 @default.
- W4360754311 hasConceptScore W4360754311C2777649267 @default.
- W4360754311 hasConceptScore W4360754311C2780456651 @default.
- W4360754311 hasConceptScore W4360754311C2781413609 @default.
- W4360754311 hasConceptScore W4360754311C530470458 @default.
- W4360754311 hasConceptScore W4360754311C71924100 @default.
- W4360754311 hasIssue "7" @default.
- W4360754311 hasLocation W43607543111 @default.
- W4360754311 hasOpenAccess W4360754311 @default.
- W4360754311 hasPrimaryLocation W43607543111 @default.
- W4360754311 hasRelatedWork W1978033271 @default.
- W4360754311 hasRelatedWork W1983252771 @default.
- W4360754311 hasRelatedWork W1989798994 @default.
- W4360754311 hasRelatedWork W1993729317 @default.
- W4360754311 hasRelatedWork W2147292731 @default.
- W4360754311 hasRelatedWork W2365277249 @default.
- W4360754311 hasRelatedWork W2388730008 @default.
- W4360754311 hasRelatedWork W2411813061 @default.
- W4360754311 hasRelatedWork W4214554217 @default.
- W4360754311 hasRelatedWork W64123703 @default.
- W4360754311 hasVolume "273" @default.
- W4360754311 isParatext "false" @default.
- W4360754311 isRetracted "false" @default.
- W4360754311 workType "article" @default.